An Evaluation of Blood Glucose Levels and Insulin Requirement After Subacromial Corticosteroid Injection in Insulin Dependent Diabetics
NCT03328975 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL
Last updated 2017-11-01
Summary
The overall purpose of this study is to evaluate the effect of a corticosteroid shoulder injection on glucose levels in insulin-dependent diabetic men and women.
Conditions
- Shoulder Injury
- Insulin-dependent Diabetics
Interventions
- DRUG
-
The overall purpose of this study is to evaluate the effect of a corticosteroid shoulder injection on glucose levels in insulin-dependent diabetic men and women.
- OTHER
-
Placebo
the placebo group will not receive the corticosteroid medication in their injection to treat the inflammation and pain in their shoulder. Instead, they will receive an injection of 5 mL lidocaine only.
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-11-01
- Primary Completion
- 2021-11-01
- Completion
- 2022-11-01
More Related Trials
-
A Study in Type 1 Diabetic Patients With Repeated Doses of E1 in Combination With G1
NCT00239148 ·Status: COMPLETED ·Phase: PHASE1
-
A Trial to Evaluate the Immunogenicity of Dasiglucagon and GlucaGen in Patients With Type 1 Diabetes Mellitus
NCT03216226 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Safety, Tolerability and Bioavailability of Dasiglucagon Following Subcutaneous (SC) Compared to IV Administration
NCT03735225 ·Status: COMPLETED ·Phase: PHASE1
-
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
NCT02460978 ·Status: COMPLETED ·Phase: PHASE3
-
Dapagliflozin Evaluation in Patients With Inadequately Controlled Type 1 Diabetes
NCT02268214 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Immunoregulatory Dendritic Cells for Type 1 Diabetes Therapy
NCT02354911 ·Status: WITHDRAWN ·Phase: PHASE2
-
Effects of PN2034 in Insulin-Dependent Patients With Type 2 Diabetes
NCT00110864 ·Status: COMPLETED ·Phase: PHASE2
-
Study Of Denagliptin In Subjects With Type 2 Diabetes Mellitus (T2DM)
NCT00387972 ·Status: WITHDRAWN ·Phase: PHASE2/PHASE3
-
Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes
NCT02325206 ·Status: COMPLETED ·Phase: PHASE1
-
In-patient Study With GSK716155 In Patients With Type 2 Diabetes Mellitus
NCT00354536 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of Dose-titration of Pramlintide During Initiation of Therapy in Patients Trying to Improve Glucose Control
NCT00042458 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Human Plasma-Derived Alpha1-Proteinase Inhibitor in Subjects With New-Onset Type 1 Diabetes Mellitus
NCT02093221 ·Status: TERMINATED ·Phase: PHASE2
-
A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
NCT00823940 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Exenatide on 24-Hour Blood Glucose Profile Compared With Placebo in Patients With Type 2 Diabetes
NCT00241423 ·Status: COMPLETED ·Phase: PHASE2
-
In-patient Study in Patients With Type 2 Diabetes Mellitus
NCT00259896 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of a Fixed Pramlintide: Insulin Dose Ratio on Postprandial Glucose in Type 1 Diabetes Mellitus
NCT02500979 ·Status: COMPLETED ·Phase: PHASE1
-
A Research Study Comparing How Well Different Doses of the Medicine NNC0487-0111 Lower Blood Sugar in People With Type 2 Diabetes
NCT06542874 ·Status: COMPLETED ·Phase: PHASE2
-
Pilot Study Evaluating Safety of ExOlin® in Patients With Poorly Controlled Type 1 Diabetes
NCT05221359 ·Status: RECRUITING ·Phase: NA
-
A Study of CT-868 in Type 1 Diabetes Mellitus
NCT06062069 ·Status: COMPLETED ·Phase: PHASE2
-
A Trial to Compare the Efficacy and Safety of 2 Different Batches of Subcutaneous Dasiglucagon in Patients With T1DM
NCT03895697 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Effects of XOMA 052 on Insulin Production in Subjects With Well Controlled Type 1 Diabetes
NCT00998699 ·Status: COMPLETED ·Phase: PHASE2
-
GALLANT 9 Tesaglitazar vs. Placebo in Combination With Insulin
NCT00242372 ·Status: TERMINATED ·Phase: PHASE3
-
BOL-DP-o-05 as an Add-On Treatment of Subjects With Newly Diagnosed Type 1 Diabetes Mellitus
NCT04102202 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Trial to Confirm the Efficacy and Safety of Dasiglucagon in the Treatment of Hypoglycemia in T1DM Children
NCT03667053 ·Status: COMPLETED ·Phase: PHASE3
-
A Randomized Control Trial Comparing Linjeta Versus Humalog in Pumps: Effect on Postprandial Blood Sugars.
NCT01067118 ·Status: WITHDRAWN ·Phase: PHASE2